Condition: Renal Tumor · Renal Cancer · Sponsor: University Hospital, Grenoble
The goal of this clinical trial is to evaluate peri and post-operative outcomes as well as long-term survival of 3D IGRAPN compared to conventional Robot-Assisted Partial Nephrectomy (RAPN) for moderate and highly complex renal tumors. The main questions aim to answer: * peri-operative complications * oncological safety * long term renal function Participants will be asked to do undergo 3D-IGRAPN. Researchers will compare 3D-IGRAPN to RAPN to see if peri-operative outcomes are better in the experimental group.
This description comes directly from the study's public registry record.
Jean-Luc DESCOTES, Pr · 0476767642 · jldescotes@chu-grenoble.fr
ASSILAH BOUZIT · 0476767971 · abouzit@chu-grenoble.fr
Always discuss trial participation with your own doctor first.
| University Hospital Grenoble | Grenoble, France | Recruiting |
| university HospitalGrenoble | Grenoble, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05572216